Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Lowry-Wood syndrome is characterized by the association of epiphyseal dysplasia, short stature, microcephaly and, in the first reported cases, congenital nystagmus. So far, less than 10 cases have been described in the literature. Variable degrees of intellectual deficit have also been reported. Other occasional features include retinitis pigmentosa and coxa vara. Transmission appears to be autosomal recessive.
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 2:54 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Lowry-Wood syndrome
Features include always present findings: Sloping forehead, Mild intellectual disability, Short stature, and Squared iliac bones and others; and common findings: Nyctalopia, Limited elbow extension, Brachydactyly, and Pigmentary retinopathy and others. 25 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Mild intellectual disability, Global developmental delay |
Growth and development | 2 | Short stature, Intrauterine growth retardation |
Bones and joints | 2 | Squared iliac bones, Multiple joint dislocation |
Eyes | 2 | Pigmentary retinopathy, Nystagmus |
Head and neck | 1 | Microcephaly |
Lungs and breathing | 1 | Restrictive ventilatory defect |
Arms and legs | 1 | Clinodactyly of the 5th finger |
Muscles | 1 | Elbow flexion contracture |
Age of onset: before birth, at birth.
To date, fewer than 100 individuals have been identified with RNU4ATAC biallelic pathogenic variants . In this GeneReview, the term "RNU4atac-opathy" refers to the entire phenotypic spectrum that can be associated with biallelic RNU4ATAC pathogenic variants. This includes the historically defined clinical diagnoses microcephalic osteodysplastic primordial dwarfism type I/III (MOPDI), Roifman syndrome, and Lowry-Wood syndrome, as well as varying combinations of disease features that do not match specific defined phenotypes . However, for the purposes of delineating the phenotypes included in the 2019 revision of the "Nosology and Classification of Genetic Skeletal Disorders" , much of the following discussion – when possible – is organized by the clinically described diagnoses.
Table 3.
Source: GeneReviews — "RNU4atac-opathy"
RNU4ATAC function has not been fully characterized.
Lowry-Wood syndrome is associated with mutations in the RNU4ATAC gene on chromosome 2.
Where no specific reference is cited, data came from the Primordial Dwarfism Registry (NCT04569149).—ED. No consensus clinical diagnostic criteria for RNU4atac-opathy have been published.
RNU4atac-opathy should be suspected in individuals with a combination of the following clinical and radiographic findings and family history.
Clinical findings
Source: GeneReviews — "RNU4atac-opathy"
The differential diagnosis of RNU4atac-opathy depends on presenting features and the severity of the findings on the phenotype spectrum. While the differential diagnosis can be narrowed for individuals with a severe phenotype, the differential diagnosis for individuals with milder growth restriction and skeletal dysplasia is extensive; thus, all genes known to be associated with the primary clinical finding (e.g., microcephaly/ skeletal dysplasia/ retinal dystrophy/ immunodeficiency) should be considered. Growth Restriction When growth restriction is extreme (occipitofrontal circumference and height 4 SD below the mean), the differential diagnosis is the same as for other forms of microcephalic dwarfism (see Microcephalic Osteodysplastic Primordial Dwarfism Type II, Differential Diagnosis). Brain malformations and skeletal features are significant discriminants in individuals with extreme growth restriction and may allow for a clinical/syndromic diagnosis of RNU4atac-opathy. Milder growth restriction has a wider differential, in which either skeletal dysplasia, retinal dystrophy, and/or immunodeficiency may provide diagnostic prompts. Skeletal Dysplasia Epiphyseal dysplasia (with or without spondylo/metaphyseal involvement) alongside microcephaly should be strongly discriminant for RNU4atac-opathy with a limited differential diagnosis, particularly if immunodeficiency and/or retinal dystrophy is also present . Individuals with RNU4atac-opathy do not always have microcephaly; therefore, absence of this clinical feature does not exclude the diagnosis. Table 7. Skeletal Dysplasias Associated with Microcephaly in the Differential Diagnosis of RNU4atac-opathy
Gene(s) |
|---|
Genetic testing for RNU4ATAC is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Lowry-Wood syndrome has been reported in the published literature.
No approved treatments are currently available for Lowry-Wood syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for RNU4atac-opathy have been published. The recommendations in this section are based on the authors' experience in caring for 20 individuals over almost 20 years. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with RNU4atac-opathy, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 8. RNU4atac-opathy: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment |
|---|---|---|
Growth | Measure height, weight, head circumference. | For MOPDI, expectation for weight gain should be exceedingly slow growth (2 g/day) |
Gastrointestinal/Feeding | To incl eval of aspiration risk nutritional status | Consider eval for gastrostomy tube placement in persons w/dysphagia /or aspiration risk. |
Skeletal dysplasia | AP/lateral full spine, flexion-extension cervical spine, AP lower extremity radiographs | To screen for scoliosis, cervical spine instability, hip dislocation, lower extremity alignment |
Cognitive impairment | Developmental assessment | To incl motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education |
Neurologic |
Source: GeneReviews — "RNU4atac-opathy"
2 trials found
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations listed in are recommended. Table 10. RNU4atac-opathy: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
Growth | In children w/MOPDI, expectation should be for exceedingly slow growth (2g/day). | At each visit |
Skeletal dysplasia | Monitor lower extremity alignment spinal curves. | Annually, through age of skeletal maturity, or more often as needed |
Cognitive impairment | Monitor developmental progress educational needs. | At each visit |
Immunodeficiency | Monitor w/immunoglobulins (IgG, IgA, IgM) complete blood count w/differential. | Annually; more often as clinically indicated; Repeat immune eval as performed on initial diagnosis may be indicated depending on course. |
Ophthalmologic | Assessment of visual acuity visual fields followed by dilated eye exam w/attention to any other potential findings due to cataracts /or progression of retinal dystrophy | Annually or as clinically indicated Low vision needs |
Cardiac | Per treating cardiologist | Per treating cardiologist |
Gastrointestinal | Per treating gastroenterologist | Per treating gastroenterologist |
Skin | Per treating dermatologist | Per treating dermatologist |
Genital | Per treating endocrinologist/urologist | Per treating endocrinologist/urologist |
Renal | Per treating nephrologist for evidence of renal dysfunction | Per treating nephrologist |
Hearing | Per treating otolaryngologist/audiologist | Per treating otolaryngologist/audiologist MOPDI = microcephalic osteod... |
Source: GeneReviews — "RNU4atac-opathy"
Phenotype severity distribution: 12 always present features, 10 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
2 clinical trials registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
75 publications have been identified in PubMed for Lowry-Wood syndrome. Research spans Case Report / Case Series (45%), Review / Meta-Analysis (16%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 33 | 45% |
Research summaries | 12 | 16% |
Laboratory research | 12 | 16% |
Clinical study results | 8 | 11% |
Disease patterns and progression | 6 | 8% |
Other research | 2 | 3% |
Testing and diagnosis research | 1 | 1% |
Gaur BK (2026). [PMID: 40990967](https://pubmed.ncbi.nlm.nih.gov/40990967/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Zhu M (2026). [PMID: 42051450](https://pubmed.ncbi.nlm.nih.gov/42051450/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
P S (2026). [PMID: 41694946](https://pubmed.ncbi.nlm.nih.gov/41694946/). *Cureus*. [Review / Meta-Analysis]
Pattani N (2026). [PMID: 41956799](https://pubmed.ncbi.nlm.nih.gov/41956799/). *J Med Genet*. [Case Report / Case Series]
Deng Q (2026). [PMID: 42170480](https://pubmed.ncbi.nlm.nih.gov/42170480/). *Am J Transl Res*. [Case Report / Case Series]
Echevarría-Marín MI (2026). [PMID: 42229480](https://pubmed.ncbi.nlm.nih.gov/42229480/). *Acta Ortop Mex*. [Review / Meta-Analysis]
Liu M (2026). [PMID: 41400824](https://pubmed.ncbi.nlm.nih.gov/41400824/). *Virulence*. [Basic Science / Preclinical]
Lovric S (2026). [PMID: 41808109](https://pubmed.ncbi.nlm.nih.gov/41808109/). *Orphanet J Rare Dis*. [Case Report / Case Series]
Zhou Q (2026). [PMID: 41772121](https://pubmed.ncbi.nlm.nih.gov/41772121/). *Langenbecks Arch Surg*. [Clinical Trial Publication]
Guevara A (2026). [PMID: 42061054](https://pubmed.ncbi.nlm.nih.gov/42061054/). *Growth Horm IGF Res*. [Epidemiology / Natural History]
Disorder
MOI |
|---|
Key Features of Disorder |
|---|
ORC6 | Meier-Gorlin syndrome (OMIM PS224690) | ARAD1 | IUGR, extreme short stature w/microcephaly; patella hypoplasia |
Saul-Wilson syndrome | AD | IUGR, extreme short stature; occasional microcephaly; retinal dystrophy hearing loss; iIntermittent neutropenia (but no known B cell defects) | Relative macrocephaly; distinct facial features; megaepiphyses; lamellar cataracts; clubfoot; normal intellect PCNT |
Microcephalic osteodysplastic primordial dwarfism type II | AR | IUGR, extreme short stature; microcephaly; neurovascular disease | Distinct facial features; renovascular cardiovascular disease; microdontia; insulin resistance |
POLE | IMAGe-I syndrome (OMIM 618336) | AR | IUGR, extreme short stature; often microcephalic; immune dysfunction (T, B, or NK cell lymphopenia or hypogammaglobulinemia) |
Source: GeneReviews — "RNU4atac-opathy"
Baseline brain MRI if not previously performed; Consider EEG if seizures are a concern.; Referral to neurologist as indicated |
Immunodeficiency | Immunologist consultation w/lab eval | Perform immunologic eval prior to administering live vaccines:; Immunoglobulins (IgG, IgA, IgM); Tetanus pneumococcal antibody titers; Complete blood count w/differential; Lymphocyte subsets Consider, based on above results infection history:; B cell phenotyping; T lymphocyte proliferation assay |
Ophthalmologic | Ophthalmologic eval | To assess for vision, abnormal ocular movement, refractive errors, strabismus, more complex findings (e.g., cataract, retinal dystrophy) that may require referral for subspecialty care /or low vision services |
Cardiac | Echocardiogram | To assess for structural malformations or evidence of cardiomyopathy |
Liver | Measure transaminases direct conjugated bilirubin levels. | Most important in neonatal period |
Genital | Assess for cryptorchidism micropenis in males. | — |
Renal | Assess renal function kidney urinary tract structure | Assess for:; Evidence of renal tubular acidosis;; Renal ultrasound for CAKUT incl cystic or dysplastic kidneys. |
Hearing loss | Otolaryngology exam | To evaluate possible causes of conductive hearing loss, if present Audiogram |
Genetic counseling | By genetics professionals1 | To inform persons w/RNU4atac-opathy their families re nature, MOI, implications of RNU4atac-opathy to facilitate medical personal decision making Family support resources |
RNU4atac-opathy: Treatment of Manifestations Manifestation/Concern | Treatment | Considerations/Other |
Growth | At severe end of phenotypic spectrum (MOPDI), gastrostomy tube Nissen fundoplication may be indicated for children who cannot orally feed, who aspirate, or who are unable to meet weight gain expectations. | Skeletal dysplasia |